Search Results

Jack Antel to its clinical advisory board Crinetics Pharmaceuticals First Quarter 2023 Earnings: Revenues

Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating

amended deal with Gilead on anti-CCR8 antibody InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical

discussed this exciting opportunity with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals

GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure Industry News X4 Pharmaceuticals

Reports Financing Highlights Neurocrine Biosciences Provides Development Pipeline Update Crinetics Pharmaceuticals

immunotherapy drug Trevena Reports Second Quarter 2023 Results and Provides Business Update Crinetics Pharmaceuticals

Phase 2 Study Part 1 IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics Crinetics Pharmaceuticals

Research Associate Research Technician Senior Research Associate, In Vitro Pharmacology - Crinetics Pharmaceuticals

Research Associate NEW Research Technician Senior Research Associate, In Vitro Pharmacology - Crinetics Pharmaceuticals

strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance Crinetics Pharmaceuticals

| Chemotactic Cytokines GPCR Jobs NEW Senior Research Associate, In Vitro Pharmacology - Crinetics Pharmaceuticals

Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage X4 Pharmaceuticals

results for metabolic disorders INDIGO Biosciences, INC as a Preferred Supplier at Prendio Crinetics Pharmaceuticals

great conversation about this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals

great conversation about this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals

Industry News Design Pharmaceuticals has a new website Confo Therapeutics Announces Global Licensing

InterAx Biotech's AI platform unlocks new drug designs for diabetes, obesity, and cancer Crinetics Pharmaceuticals

17th, 2024 Industry News Centessa Launches Phase 2 Trial of ORX750 for Narcolepsy and IH Crinetics Pharmaceuticals

QRFP receptor GPR103 Industry News EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals

extraordinary opportunity to generate proprietary chemo-informatics for GPCR drug discovery - Design Pharmaceuticals

Mark discussed this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals

This reactive approach, driven by a "go fast" mindset, burns through precious capital and time, leaving This reactive approach, driven by the prevailing wisdom of "going fast" and focusing only on the science This simple truth applies profoundly to the "go fast" culture in biotech. This is the critical piece that often gets lost in the "go fast" culture—the integration of science with

Data arrives too fast and too fragmented CROs deliver output without clear integration Teams chase the wrong assays, too late to pivot Milestones slip—and nobody realizes until it’s too late Failing fast This is embedded consulting for biotech and VC teams who need to move fast —without compromising scientific

Can the pharmaceutical industry reduce attrition rates? Acta Pharmaceutica Sinica B. 2022;12(7):3049-3062. 6.            Wouters OJ, McKee M, Luyten J. Innovation in the pharmaceutical industry: New estimates of R&D costs.

. ✅ When your pitch follows this logic, it respects the listener’s time, builds trust fast, and moves Fast. 👉 Biotech founders don’t lose opportunities because their ideas are weak. It’s about making your value obvious, fast. 👉 The goal is not to simplify your science. your narrative, making tough tradeoffs, or simply feeling stuck, this session will get you unstuck, fast

drug discovery, you know the pressure: timelines are tight, resources finite, and decisions must be fast Yet some assumptions still shaping pharmacology workflows haven’t evolved as fast as today’s science.

GPCR Premium: Sneak Peek A fast editorial preview of what Premium Members get in full this week — so Fast FAQ 🔹 What’s included? GPCR scientists, translational pharmacologists, discovery teams, and decision-makers who need fast, curated

industry insights, event updates, jobs, and classified publications—curated for scientists who need fast GPCR Premium is designed for scientists who need the right intelligence, fast—without noise, distractions GPCR Premium gives you an edge in a fast-moving field.

Running Too Hard, Too Fast In research, there’s always more to do. Grants. Experiments.